| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,903 |
6,212 |
$339K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,397 |
5,491 |
$206K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,539 |
5,613 |
$201K |
| 80061 |
Lipid panel |
16,014 |
13,609 |
$187K |
| 84443 |
Thyroid stimulating hormone (TSH) |
13,574 |
11,638 |
$187K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,789 |
6,209 |
$160K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,106 |
20,245 |
$156K |
| 80074 |
|
3,484 |
2,897 |
$153K |
| 80053 |
Comprehensive metabolic panel |
17,097 |
14,514 |
$151K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
5,280 |
4,333 |
$103K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12,012 |
10,167 |
$98K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,381 |
1,955 |
$93K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,094 |
3,429 |
$84K |
| 82274 |
|
5,792 |
4,888 |
$82K |
| 84439 |
|
8,216 |
7,154 |
$67K |
| 81000 |
|
17,744 |
15,036 |
$50K |
| 86738 |
|
2,464 |
2,359 |
$31K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,611 |
1,727 |
$28K |
| 87276 |
|
2,363 |
2,254 |
$26K |
| 87275 |
|
2,371 |
2,264 |
$26K |
| 84153 |
|
1,573 |
1,306 |
$25K |
| 86592 |
|
6,459 |
5,582 |
$24K |
| 82607 |
|
1,725 |
1,461 |
$23K |
| 86701 |
|
2,569 |
2,409 |
$22K |
| 87088 |
|
2,340 |
2,011 |
$17K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,140 |
1,766 |
$16K |
| 82043 |
|
1,921 |
1,491 |
$11K |
| 86803 |
|
778 |
738 |
$10K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
187 |
178 |
$9K |
| 83655 |
|
799 |
662 |
$9K |
| 87581 |
|
294 |
194 |
$8K |
| 86328 |
|
446 |
433 |
$8K |
| 82570 |
|
1,603 |
1,124 |
$8K |
| 86849 |
|
357 |
279 |
$7K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
221 |
203 |
$7K |
| 85730 |
|
1,243 |
1,019 |
$7K |
| 80050 |
General health panel |
726 |
694 |
$7K |
| 82728 |
|
387 |
293 |
$5K |
| 85610 |
|
1,227 |
1,004 |
$4K |
| 84702 |
|
292 |
245 |
$4K |
| 87807 |
|
377 |
296 |
$4K |
| 87340 |
|
384 |
327 |
$4K |
| 83001 |
|
190 |
153 |
$3K |
| 84436 |
|
625 |
458 |
$3K |
| 83002 |
|
189 |
152 |
$3K |
| 86710 |
|
120 |
118 |
$3K |
| 87536 |
|
41 |
29 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
527 |
492 |
$3K |
| 85651 |
|
821 |
693 |
$3K |
| 87390 |
|
211 |
206 |
$2K |
| 84146 |
|
117 |
102 |
$2K |
| 84156 |
|
633 |
517 |
$2K |
| 84703 |
|
313 |
276 |
$2K |
| 86702 |
|
211 |
207 |
$2K |
| 83540 |
|
191 |
134 |
$1K |
| 87177 |
|
207 |
202 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
137 |
76 |
$1K |
| 86038 |
|
96 |
79 |
$1K |
| 84403 |
|
40 |
26 |
$995.29 |
| 82947 |
|
328 |
270 |
$957.78 |
| 83550 |
|
99 |
79 |
$794.93 |
| 87338 |
|
65 |
51 |
$642.52 |
| 86360 |
|
15 |
13 |
$604.04 |
| 86141 |
|
101 |
69 |
$544.13 |
| 82105 |
|
57 |
44 |
$502.87 |
| 86703 |
|
32 |
32 |
$364.79 |
| 86431 |
|
43 |
37 |
$224.44 |
| 82950 |
|
46 |
38 |
$210.83 |
| 84479 |
|
48 |
24 |
$209.78 |
| 86140 |
|
44 |
40 |
$199.23 |
| 82746 |
|
15 |
13 |
$163.03 |
| 80076 |
|
31 |
24 |
$134.63 |
| 82951 |
|
42 |
39 |
$91.36 |
| 85027 |
|
15 |
15 |
$88.93 |
| 84520 |
|
21 |
12 |
$79.04 |
| 84550 |
|
13 |
13 |
$52.01 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
12 |
12 |
$15.90 |
| 3051F |
|
15 |
12 |
$0.00 |
| 3048F |
|
44 |
44 |
$0.00 |
| 3049F |
|
29 |
29 |
$0.00 |